secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2026-05-29T21:00:24+00:00
Accession:  0001493152-26-026415
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics issues amended warrant for 17.4M shares at $0.23, subject to stockholder approval
--------------------------------------------------------------------------------

- Issued amended warrant to accredited investor for 17,391,304 unvested shares at $0.23 exercise price.
- Exercise conditioned on stockholder approval; minimum vesting acquisition amount increased to $1M from $500K.
- Vesting termination date extended from July 8, 2026 to September 30, 2026.
- Private placement exempt under Section 4(a)(2) and Rule 506(b); shares not registered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/0001493152-26-026415-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226026415/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026415

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer